Recital 7, Regulation (EU) 2022/966

In forcesince 21 Jun 2022

The Commission considers that the requested update of the Union list concerning specifications of Calanus finmarchicus oil and the resulting changes in its conditions of use for the population groups older than 14 years of age is not liable to have an effect on human health and that a safety evaluation by the European Food Safety Authority (‘the Authority’) in accordance with Article 10(3) of Regulation (EU) 2015/2283 is not necessary. The increase in the astaxanthin esters in oil from Calanus finmarchicus from < 0,1 % to ≤ 0,25 % in food supplements intended for population groups older than 14 years is expected to result in intakes of astaxanthin esters which, in combination with the intake of astaxanthin from the normal diet, are not expected to exceed the revised Acceptable Daily Intake (‘ADI’) of 0,2 mg astaxanthin/kg bw, established by the Authority [Safety of astaxanthin for its use as a novel food in food supplements; EFSA Journal 2020;18(2):5993.].